June 26-29, 2022

Annual Meeting of the European Society of Mycobacteriology

Meet us at the 42nd Annual Meeting of the European Society of Mycobacteriology (ESM), from June 26 to 29, 2022 in Bologna - Italy.

More information

June 10, 2022

Annual Meeting of the French Helicobacter Study Group

Meet us at the 29th Annual Meeting of the French Helicobacter Study Group (GEFH), on June 10, 2022 in Paris - France.

More information (in french)

March 10, 2022

Adebiotech Webinar "Applications of High Throughput Sequencing"

Meet us at the Adebiotech Webinar "Applications of High Throughput Sequencing" on March 10, 2022.

More information (french)

From Nov. 30 to Dec. 2, 2021

Food Ingredients Europe 2021, Frankfurt - Germany

Meet us at the "Food Ingredients Europe" conference in Frankfurt from November 30th to December 2nd 2021.
We will welcome you on our booth N°31H94

More information

April 23-26, 2022

ECCMID 2022, Lisbon - Portugal

Find us at the 32nd European Congress of Clinical Microbiology and Infectious Diseases, in Lisbon - Portugal, April 23-26, 2022.

Read more

From October 27 to 29, 2021

14th Congress "Yeast, Models and Tools" in Strasbourg - France

Meet us at the 14th Congress "Yeast, Models and Tools" which will take place in Strasbourg, from October 27 to 29, 2021.

En savoir plus

October 28 and 29, 2021

annual joint Congress of the French Societies of Medical Mycology and Parasitology, Lyon - France

Meet us at the annual joint Congress of the French Societies of Medical Mycology and Parasitology which will take place in Lyon on October 28 and 29, 2021.

En savoir plus (French only)

Subcategories

GenoScreen develops its technologies and know-how in genomics within a dense, well-structured network of partners.


These collaborations co-fund ambitious research programs and jointly develop innovative technologies: an effective and agile strategy that opens up new opportunities for our staff.

GenoScreen is a partner in collaborative research projects that bring together startups, multinationals and public-sector organizations. Our R&D teams provide their knowledge and expertise in the molecular microbiology of isolated agents and complex communities. This allowed our teams to develop our own projects for elaborating innovative products and services.

Our projects are designed to:

  • Improve the diagnosis and management of acute/chronic diseases on humans and animals,
  • Characterize and monitor microbial biodiversity, with applications in agronomy, agrifood and environment.

The common feature of these projects is the development of molecular tools for the characterization, monitoring and diagnosis of microbial communities. The key objective is to market simple analytical solutions and (ultimately) preventive, corrective or even therapeutic products based on microorganisms.